The role of fibroblast growth factor 23 in inflammation and anemia
In patients with chronic kidney disease (CKD), adverse outcomes such as systemic
inflammation and anemia are contributing pathologies which increase the risks for …
inflammation and anemia are contributing pathologies which increase the risks for …
MMP-2 and its implications on cardiac function and structure: interplay with inflammation in hypertension
Hypertension is one of the leading risk factors for the development of heart failure. Despite
being a multifactorial disease, in recent years, preclinical and clinical studies suggest strong …
being a multifactorial disease, in recent years, preclinical and clinical studies suggest strong …
Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers
Background. Increased levels of inflammatory biomarkers such as interleukin-6 (IL-6), 10 (IL-
10), 1β (IL-1β), tumor necrosis factor-α (TNF-α) high-sensitivity C-reactive protein (hs-CRP) …
10), 1β (IL-1β), tumor necrosis factor-α (TNF-α) high-sensitivity C-reactive protein (hs-CRP) …
ADAM17, a key player of cardiac inflammation and fibrosis in heart failure development during chronic catecholamine stress
Heart failure development is characterized by persistent inflammation and progressive
fibrosis owing to chronic catecholamine stress. In a chronic stress state, elevated …
fibrosis owing to chronic catecholamine stress. In a chronic stress state, elevated …
Experimental and human evidence for lipocalin‐2 (neutrophil gelatinase‐associated lipocalin [NGAL]) in the development of cardiac hypertrophy and heart failure
Background Cardiac hypertrophy increases the risk of develo** heart failure and
cardiovascular death. The neutrophil inflammatory protein, lipocalin‐2 (LCN 2/NGAL), is …
cardiovascular death. The neutrophil inflammatory protein, lipocalin‐2 (LCN 2/NGAL), is …
Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study
Background Left ventricular hypertrophy (LVH) and myocardial contractile dysfunction are
independent predictors of mortality in patients with chronic kidney disease (CKD). The …
independent predictors of mortality in patients with chronic kidney disease (CKD). The …
Increased neutrophil to lymphocyte ratio in patients with resistant hypertension
E Belen, A Sungur, MA Sungur… - The Journal of Clinical …, 2015 - Wiley Online Library
Resistant hypertension (RHT) is an important disease that causes an increase in
cardiovascular risk, yet its etiology remains unclear. The authors aimed to investigate …
cardiovascular risk, yet its etiology remains unclear. The authors aimed to investigate …
Hypertension, inflammation and atrial fibrillation
Atrial fibrillation is the most common cardiac arrhyth-mia in clinical practice and is a major
risk factor for stroke and mortality [1]. It affects approximately 1–2% of the general …
risk factor for stroke and mortality [1]. It affects approximately 1–2% of the general …
Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience
B Hitha, JM Pappachan, HB Pillai… - Saudi Journal of …, 2008 - journals.lww.com
Persistent microalbuminuria (MA) is the earliest indicator of chronic kidney disease (CKD) in
patients with diabetes mellitus and hypertension. Patients with MA have high risk for target …
patients with diabetes mellitus and hypertension. Patients with MA have high risk for target …
Urinary albumin excretion is associated with true resistant hypertension
A Oliveras, P Armario, R Hernández-Del Rey… - Journal of human …, 2010 - nature.com
Resistant (or refractory) hypertension (RH) is a clinical diagnosis based on blood pressure
(BP) office measurements. About one third of subjects with suspected RH have indeed …
(BP) office measurements. About one third of subjects with suspected RH have indeed …